Laxmi Dental Limited (LAXMIDENTL)

Healthcare · Healthcare Equipment & Supplies · NSE · Updated 21 July 2026

₹224.84 ↓ 54.83% (1Y)

🎯 Key Takeaways

Laxmi Dental Limited is transitioning from a traditional dental equipment manufacturer to a digitally integrated solutions provider, with management actively investing in automation, digital platforms, and export expansion to drive margin growth and market penetration. The company is in a strategic reinvestment phase, leveraging its IPO proceeds to scale digital dentistry offerings while targeting EBITDA margins of 18-20% by FY27-FY28.
⚠️ Execution risk in achieving 90% scanner penetration and margin expansion targets depends on timely integration of digital platforms and automation.

Market Cap

₹1,105

P/E Ratio

57.2

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About LAXMIDENTL 📊 Interactive Charts

📖 The Story

Laxmi Dental Limited is transitioning from a traditional dental equipment manufacturer to a digitally integrated solutions provider, with management actively investing in automation, digital platforms, and export expansion to drive margin growth and market penetration. The company is in a strategic reinvestment phase, leveraging its IPO proceeds to scale digital dentistry offerings while targeting EBITDA margins of 18-20% by FY27-FY28.

📰 What's Happening

In Q4FY26, revenue grew 16.2% YoY to ₹277.9 crores, driven by strong performance in digital dentistry and exports constituting 33-34% of total revenue. Management launched the iScope 360 remote aligner monitoring platform and highlighted progress toward 90% scanner penetration from the current 80%. A proposed merger of Bizdent Devices with the parent company was approved, and the company is utilizing IPO proceeds of ₹138 crores for strategic investments, with ICRA validating compliance with SEBI norms and fund deployment timelines.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q3FY25
Revenue	62
Operating Profit	10
OPM %	15.6%
Net Profit	5
EPS	₹0.88

Revenue trends show consistent growth, with Q3FY25 revenue at ₹62 crores and full-year FY26 revenue reaching ₹277.9 crores, reflecting 16.2% YoY expansion. EBITDA margin improved to 15.6% for the full year, supported by digital investments and operational efficiencies, though still below the 18-20% target for FY27-FY28. Profitability remains stable with PAT margin held within the 13-15% guidance range, indicating disciplined cost management amid scaling digital initiatives.

🔮 Management Outlook & What's Next

Management has provided forward-looking guidance targeting EBITDA margin expansion to 18-20% by FY27-FY28, driven by automation, digital adoption, and scale in export markets. They also reaffirmed PAT margin targets of 13-15%, underpinned by cost control and higher-margin digital product mix. No specific revenue growth guidance was disclosed, but digital penetration goals suggest sustained investment in product innovation and market expansion.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Healthcare Equipment & Supplies

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Poly Medicure Limited	15,193	46.4	—	—	—
Fischer Medical Ventures Limited	2,261	59.0	—	—	—
Laxmi Dental Limited	1,105	57.2	—	—	—
Tarsons Products Limited	1,101	36.9	—	—	—
Fabtech Technologies Limited	681	—	—	—	—
Nureca Limited	260	-47.3	—	—	—

🔗 Peer Stock Analyses

POLYMED FISCHER TARSONS FABTECH NURECA

⚠️ Risk Factors

1. Execution risk in achieving 90% scanner penetration and margin expansion targets depends on timely integration of digital platforms and automation. 2. Export growth may face headwinds from US tariffs at 10%, potentially impacting gross margins if cost pass-through is limited. 3. Integration risks associated with the proposed merger of Bizdent Devices could disrupt operations or dilute focus if not managed efficiently.

📋 Recent Filings

🧠 Analyst's Read

Laxmi Dental is positioning itself as a digitally enabled dental solutions provider with clear margin expansion ambitions, supported by strategic investments and export growth. Investors should monitor execution of digital initiatives, progress toward scanner penetration targets, and clarity on merger integration in the upcoming quarters.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on LAXMIDENTL

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-21.

📡 Get AI alerts when LAXMIDENTL files new disclosures

Track LAXMIDENTL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LAXMIDENTL — Free

Free account · 2 AI queries/day